Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 1
2017 3
2018 2
2019 4
2020 5
2021 11
2022 7
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study.
Ukrainskaya V, Molostova O, Shelikhova L, Pershin D, Kulakovskaya E, Volkov D, Rakhteenko A, Muzalevskii Y, Kazachenok A, Brilliantova V, Osipova D, Rubtsov Y, Stepanov A, Maschan M. Ukrainskaya V, et al. Among authors: shelikhova l. Blood Adv. 2022 Oct 11;6(19):5582-5588. doi: 10.1182/bloodadvances.2021006262. Blood Adv. 2022. PMID: 35446932 Free PMC article. No abstract available.
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells.
Mikhailova E, Illarionova O, Shelikhova L, Zerkalenkova E, Molostova O, Olshanskaya Y, Novichkova G, Maschan A, Maschan M, Popov A. Mikhailova E, et al. Among authors: shelikhova l. Haematologica. 2022 Apr 1;107(4):970-974. doi: 10.3324/haematol.2021.279677. Haematologica. 2022. PMID: 34911282 Free PMC article. No abstract available.
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients.
Maschan M, Caimi PF, Reese-Koc J, Sanchez GP, Sharma AA, Molostova O, Shelikhova L, Pershin D, Stepanov A, Muzalevskii Y, Suzart VG, Otegbeye F, Wald D, Xiong Y, Wu D, Knight A, Oparaocha I, Ferencz B, Roy A, Worden A, Kruger W, Kadan M, Schneider D, Orentas R, Sekaly RP, de Lima M, Dropulić B. Maschan M, et al. Among authors: shelikhova l. Nat Commun. 2021 Dec 10;12(1):7200. doi: 10.1038/s41467-021-27312-6. Nat Commun. 2021. PMID: 34893603 Free PMC article.
Safety and efficacy of the low-dose memory (CD45RA-depleted) donor lymphocyte infusion in recipients of αβ T cell-depleted haploidentical grafts: results of a prospective randomized trial in high-risk childhood leukemia.
Dunaikina M, Zhekhovtsova Z, Shelikhova L, Glushkova S, Nikolaev R, Blagov S, Khismatullina R, Balashov D, Kurnikova E, Pershin D, Muzalevskii Y, Kazachenok A, Osipova E, Miakova N, Litvinov D, Novichkova G, Maschan A, Maschan M. Dunaikina M, et al. Among authors: shelikhova l. Bone Marrow Transplant. 2021 Jul;56(7):1614-1624. doi: 10.1038/s41409-021-01232-x. Epub 2021 Feb 16. Bone Marrow Transplant. 2021. PMID: 33594278 Clinical Trial.
Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy.
Mikhailova E, Illarionova O, Komkov A, Zerkalenkova E, Mamedov I, Shelikhova L, Olshanskaya Y, Miakova N, Novichkova G, Karachunskiy A, Maschan M, Popov A. Mikhailova E, et al. Among authors: shelikhova l. Cancers (Basel). 2022 Nov 5;14(21):5445. doi: 10.3390/cancers14215445. Cancers (Basel). 2022. PMID: 36358863 Free PMC article.
32 results